Patient characteristics, treatment patterns, and outcomes of Rickettsial diseases among a commercially insured population in the United States, 2005–2017

[1]  A. Hinckley,et al.  Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018 , 2021, Emerging infectious diseases.

[2]  M. Meltzer,et al.  Epidemiology and cost of Lyme disease‐related hospitalizations among patients with employer‐sponsored health insurance—United States, 2005–2014 , 2020, Zoonoses and public health.

[3]  C. Cherry,et al.  Trends in clinical diagnoses of typhus group rickettsioses among a large U.S. insurance claims database , 2020, Zoonoses and public health.

[4]  A. Binder,et al.  Diagnostic Methods Used to Classify Confirmed and Probable Cases of Spotted Fever Rickettsioses — United States, 2010–2015 , 2019, MMWR. Morbidity and mortality weekly report.

[5]  J. Fergie,et al.  Murine Typhus in South Texas Children: An 18-year Review , 2018, The Pediatric infectious disease journal.

[6]  O. Ruuskanen,et al.  Dental staining after doxycycline use in children , 2017, The Journal of antimicrobial chemotherapy.

[7]  C. Paddock,et al.  Fatal Flea-Borne Typhus in Texas: A Retrospective Case Series, 1985–2015 , 2017, The American journal of tropical medicine and hygiene.

[8]  B. Pritt,et al.  Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[9]  C. Paddock,et al.  National Surveillance of Spotted Fever Group Rickettsioses in the United States, 2008-2012. , 2016, The American journal of tropical medicine and hygiene.

[10]  Shubhayu Saha,et al.  Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005–2010 , 2015, Emerging infectious diseases.

[11]  G. Emerson,et al.  Risk factors for fatal outcome from rocky mountain spotted Fever in a highly endemic area-Arizona, 2002-2011. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. McQuiston,et al.  No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. , 2015, The Journal of pediatrics.

[13]  Rickettsial Diseases , 2015, Red Book (2015).

[14]  J. McQuiston,et al.  Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever. , 2014, The Journal of pediatrics.

[15]  Mary J. Lancaster,et al.  Knowledge, attitudes, and practices regarding Rocky Mountain spotted fever among healthcare providers, Tennessee, 2009. , 2013, The American journal of tropical medicine and hygiene.

[16]  M. Kollef,et al.  The Importance of Early Treatment With Doxycycline in Human Ehrlichiosis , 2008, Medicine.

[17]  M. Nussinovitch,et al.  Absence of Tooth Staining With Doxycycline Treatment in Young Children , 2007, Clinical pediatrics.

[18]  R. Jacobs,et al.  Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. , 2007, The Journal of pediatrics.

[19]  R. Brantley.  Trimethoprim-sulfamethoxazole and fulminant ehrlichiosis. , 2001, The Pediatric infectious disease journal.

[20]  J. Purvis,et al.  Doxycycline use for rickettsial disease in pediatric patients. , 2000, The Pediatric infectious disease journal.

[21]  T. R. Peters,et al.  Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole. , 2000, The Pediatric infectious disease journal.

[22]  R. Patel,et al.  Near fatal acute respiratory distress syndrome in a patient with human ehrlichiosis. , 1999, Southern medical journal.

[23]  W. Wilkinson,et al.  Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  R. Holman,et al.  National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. , 1995, The American journal of tropical medicine and hygiene.

[25]  C. Helmick,et al.  Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. , 1984, The Journal of infectious diseases.

[26]  R. Fontaine,et al.  Fatal Rocky Mountain spotted fever. , 1978, JAMA.

[27]  G. Harrell.  ROCKY MOUNTAIN SPOTTED FEVER , 1949, Medicine.

[28]  N. Topping.  Experimental Rocky Mountain Spotted Fever and Endémie Typhus treated with Prontosil or Sulfapyridine. , 1939 .